Clinical Trials

Glioma

NCT04908709 2026-03-04

Spectroscopic MRI Guided Proton Therapy in Assessing Metabolic Change in Pediatric Patients With Brain Tumors

25 enrolled

Malignant Brain Glioma

NCT06322602 2026-03-03

Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain Tumors

20 enrolled

Brain Neoplasms

NCT07447531 2026-03-03

T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas

15 enrolled

Glioma

NCT04047264 2026-02-12

Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies

100 enrolled

Brain Neoplasms, Glioblastoma, Glioma

NCT05775939 2026-02-10

PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial

20 enrolled

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

NCT06055881 2026-02-06

BOSS

45 enrolled

Breast

Breast Neoplasms

NCT07276438 2026-02-05

Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial

186 enrolled

Prostatic Neoplasms

NCT07188532 2026-01-23

BEAR

141 enrolled

Sarcoma

Sarcoma, Ewing

NCT05526417 2026-01-16

Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma

30 enrolled

Sarcoma

NCT07339085 2026-01-15

Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis

42 enrolled

Brain Neoplasms

NCT04151940 2026-01-14

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04251052 2026-01-14

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

1,956 enrolled

Gynecologic

Ovarian Neoplasms

NCT06788886 2025-12-30

Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

CNSEndocrineGenitourinaryNET

147 enrolled

Brain Neoplasms, Multiple Sclerosis, Prostatic Neoplasms, Neuroendocrine Tumors

NCT07074756 2025-12-24

A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma

120 enrolled

Glioma

NCT06090903 2025-11-10

Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma

50 enrolled

Glioblastoma

NCT06995053 2025-11-10

ILLUSION

Prostatic Neoplasms

NCT07091864 2025-11-10

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

116 enrolled

Glioblastoma

NCT07121972 2025-11-06

Mirai-MRI: Validation of AI Models for Breast Cancer Risk

400 enrolled

Breast

Cancer Risk

NCT05746325 2025-10-27

Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer

5 enrolled

BreastCNSThoracic

Breast Neoplasms, Lung Neoplasms, Meningeal Carcinomatosis

NCT06389786 2025-10-24

Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer

50 enrolled

Prostatic Neoplasms

NCT06325046 2025-10-16

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

144 enrolled

Prostatic Neoplasms

NCT00870129 2025-10-10

Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

135 enrolled

Brain Neoplasms, Glioma

NCT05802186 2025-10-08

Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

70 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03729115 2025-10-01

CAPS

400 enrolled

Breast

Breast Neoplasms

NCT05710380 2025-10-01

MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

180 enrolled

Prostatic Neoplasms

NCT06330441 2025-09-25

ScrePan

700 enrolled

Genetic Diseases, Inborn, Pancreatitis, Chronic

NCT06421142 2025-09-15

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

Urinary Bladder Neoplasms

NCT04424719 2025-09-03

SALOME

700 enrolled

Dermatologic

Uveal Melanoma

NCT06549725 2025-08-01

Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening

419 enrolled

Gastrointestinal

Pancreatic Neoplasms, Genetic Diseases, Inborn, Pancreatitis, Chronic

NCT06580015 2025-07-18

[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer

20 enrolled

Prostatic Neoplasms

NCT06682442 2025-04-20

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

66 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT06630845 2025-03-20

Comparison of Whole Body DWI to FDG PET

30 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT05961982 2025-03-04

ERASE

84 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06557512 2025-01-08

SRS-AIM

23 enrolled

Meningioma

NCT03116412 2024-12-16

TRIM

1,300 enrolled

Dermatologic

Melanoma

NCT05662540 2024-10-26

PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma

40 enrolled

Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT04534543 2024-08-02

MAESTRO

70 enrolled

Gastrointestinal

Gastrointestinal Neoplasms

NCT06450080 2024-06-10

ClimaBio

60 enrolled

Tumor-Agnostic

Carcinoma, Squamous Cell

NCT05977803 2024-04-09

ACROP